1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > World Smart Syringes Market - Opportunities and Forecasts, 2014 - 2020

Smart syringes can be defined as medical devices that are engineered with safety mechanisms to prevent the reuse of syringes and regulates unsafe injection practices. Smart syringes are designed with features to protect the person being injected from needle stick injuries, blood-borne diseases such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV) and resulting deadly infections. They cater to a wide range of applications that include vaccination, drug delivery, and blood specimen collection. Different types of smart syringes including auto disable (AD) syringes, passive safety syringes and active safety syringes are used depending on the nature of application. Active safety syringes are the most common type of smart syringes used across all healthcare sectors, whereas, auto disable (AD) syringes are the most popular syringes used for vaccination purposes. The world smart syringes market was evaluated at $4.8 billion in 2015, and is estimated to garner $7.6 billion by 2020, registering a CAGR of 9.6% over the forecast period. The world smart syringes market is driven by increasing count of needle stick injuries, high prevalence of blood-borne transmission such as Hepatitis B, C, HIV through improper injection practices, growing adoption of safety syringes and technological advancements. In addition, mandatory recommendation by WHO to switch to smart syringes ensuring safe injection practices is the major factor boosting the market growth. However, the high cost associated with smart syringes especially passive safety syringes, low awareness in developing economies and alternative drug delivery methods are likely to impede the market growth. The world smart syringes market volume is projected to reach 15.8 billion units by 2020 and is projected to grow at a CAGR of 8.2 during the forecast period. The world smart syringes market is segmented based on types, applications, end users and geography. The type segment is further categorized into auto disable (AD) syringes, active safety syringes and passive safety syringes. Active safety syringes accounts for the highest revenue in 2015, owing to established market position. Furthermore, auto disable (AD) syringes are especially used for vaccination purposes and are designed specifically for single use, embedded with an internal mechanism that blocks the barrel once used, thereby preventing its further usage. The world smart syringes market by application is categorized into drug delivery, vaccination, and blood specimen collection. Among these, the drug delivery segment generated the highest revenue in 2015. Several advantages associated with syringes such as better bioavailability of intravenous drugs, shorter onset time, accurate titration of the dosage, among others have boosted the market growth. Based on end user, the smart syringes market is categorized into hospitals, diabetic patients, family practices, and psychiatrics among others. Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA. North America would continue to dominate the market until 2020, on account of higher adoption of smart syringes, high awareness among the consumers about smart syringes and high healthcare expenditure across the region. Competitive Intelligence on prominent manufacturers of smart syringes provide key insights in terms of strategies implemented to gain significant share in the smart syringes market. Becton, Dickinson & Company are the leading player that provides a wide range of smart syringes across all healthcare sectors worldwide. Few of the smart syringes provided by these company include BD Eclipse and BD SafetyGlide syringes (uses active system), BD AutoShield Duo Pen Needle (passive mechanism), and BD Soloshot IX Auto-Disable 0.5 mL syringe among others. The key companies operating in the world smart syringes market include Becton, Dickinson and Company, Medtronic (Covidien), Terumo Medical Corporation, B. Braun Melsungen AG, Baxter International, Smiths Group plc, Unilife Corporation, Revolutions Medical Corporation and Retractable Technologies, Inc., among others. 

KEY BENEFITS
:This report provides an extensive analysis of the current and emerging market trends and dynamics in the world smart syringes market.The smart syringes market scenario has been comprehensively analyzed on the basis of key geographical regions.The report provides a detailed analysis of the current market and estimations from 2014 to 2020, which would enable the stakeholders to capitalize on the prevailing market opportunities.A comprehensive analysis of the market scenario in terms of applications, types, end users, and geography helps in identifying the prevailing opportunities in the world smart syringes market.The key market players operating in the market have been profiled in the report, and their strategies have been thoroughly analyzed to understand the competitive outlook of the market.SMART SYRINGES MARKET KEY SEGMENTS:Market By TypeAuto disable syringesActive safety syringesPassive safety syringesMarket By ApplicationDrug deliveryVaccinationBlood specimen collectionMarket By End UserHospitals and HMOsDiabetic patientsFamily practices (Physicians)PsychiatricsOthersMarket By GeographyNorth AmericaEuropeAsia-PacificLAMEA

Table Of Contents

World Smart Syringes Market - Opportunities and Forecasts, 2014 - 2020
CHAPTER 1 INTRODUCTION1.1 Report description1.2 Key benefits1.3 Key market segments1.4 Research methodology1.4.1 Secondary research1.4.2 Primary research1.4.3 Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARY2.1 CXO perspective2.2 Market beyond what to expect by 2025 ($Million)2.2.1 Moderate growth scenario2.2.2 Rapid growth scenario2.2.3 Diminishing growth scenarioCHAPTER 3 MARKET OVERVIEW3.1 Market definition and scope3.2 Key findings3.2.1 Top investment pockets3.2.2 Top winning strategies3.3 Porters five forces analysis3.3.1 Low bargaining power of supplier3.3.2 High bargaining power of buyer3.3.3 Fierce competition among manufacturers3.3.4 Moderate threat of substitutes3.3.5 High threat of new entrants3.4 Value chain analysis3.5 Market share analysis, (2014)3.6 Government regulations3.7 Market dynamics3.7.1 Drivers3.7.2 Restraints3.7.3 OpportunitiesCHAPTER 4 WORLD SMART SYRINGES MARKET BY TYPE, 2014-20204.1 Overview4.1.1 Key market trends4.1.2 Key growth factors and opportunities4.1.3 Market size and forecast4.2 Auto-disable syringes4.2.1 Key market trends4.2.2 Key growth factors and opportunities4.2.3 Market size and forecast4.3 Active safety syringes4.3.1 Key market trends4.3.2 Key growth factors and opportunities4.3.3 Market size and forecast4.4 Passive safety syringes4.4.1 Key market trends4.4.2 Key growth factors and opportunities4.4.3 Market size and forecastCHAPTER 5 WORLD SMART SYRINGES MARKET BY APPLICATION, 2014-20205.1 Overview5.1.1 Market size and forecast5.2 Drug delivery5.2.1 Market size and forecast5.3 Vaccination5.3.1 Market size and forecast5.4 Blood Specimen Collection5.4.1 Market size and forecastCHAPTER 6 WORLD SMART SYRINGES MARKET BY END USERS, 2014-20206.1 Overview6.1.1 Market size and forecast6.2 Hospitals and HMOs6.2.1 Market size and forecast6.3 Diabetic patients6.3.1 Market size and forecast6.4 Family practices (Physicians)6.4.1 Market size and forecast6.5 Psychiatrics6.5.1 Market size and forecast6.6 Others6.6.1 Market size and forecastCHAPTER 7 WORLD SMART SYRINGES MARKET BY GEOGRAPHY, 2014-20207.1 Overview7.1.1 Market size and forecast7.2 North America7.2.1 Key market trends7.2.2 Key growth factors and opportunities7.2.3 Market size and forecast7.3 Europe7.3.1 Key market trends7.3.2 Key growth factors and opportunities7.3.3 Market size and forecast7.4 Asia Pacific7.4.1 Key market trends7.4.2 Key growth factors and opportunities7.4.1 Market size and forecast7.5 LAMEA7.5.1 Key market trends7.5.2 Key growth factors and opportunities7.5.3 Market size and forecastCHAPTER 8 COMPANY PROFILES8.1 Becton, Dickinson and Co.8.1.1 Company overview8.1.2 Company snapshot8.1.3 Business performance8.1.4 Key strategies and recent developments8.1.5 SWOT analysis8.2 Medtronic Plc (Covidien)8.2.1 Company overview8.2.2 Company snapshot8.2.3 Business performance8.2.4 Key strategies and developments8.2.5 SWOT analysis8.3 Terumo Medical Corporation8.3.1 Company overview8.3.2 Company snapshot8.3.3 Business performance8.3.4 SWOT analysis8.4 B. Braun Melsungen AG8.4.1 Company overview8.4.2 Company snapshot8.4.3 Business performance8.4.4SWOT analysis8.5 Baxter International8.5.1 Company overview8.5.2 Company snapshot8.5.3 Business performance8.5.4 Key strategies and development8.5.5 SWOT analysis8.6 Smiths Group plc8.6.1 Company overview8.6.2 Company snapshot8.6.3 Business performance8.6.4 Key strategies and development8.6.5 SWOT analysis8.7 Unilife Corporation8.7.1 Company overview8.7.2 Company snapshot8.7.3 Business performance8.7.4 Key strategies and development8.7.5 SWOT analysis8.8 Revolutions Medical Corporation8.8.1 Company overview8.8.2 Company snapshot8.8.3 Business performance8.8.4 Key strategies and development8.8.5 SWOT analysis8.9 Retractable Technologies, Inc.8.9.1 Company overview8.9.2 Company snapshot8.9.3 Business performance8.9.4 SWOT analysisList of FiguresFIG. 1 IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO (2020-2025)FIG. 2 IMPACT ANALYSIS OF RAPID GROWTH SCENARIO (2020-2025)FIG. 3 IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO (2020-2025)FIG. 4 TOP INVESTMENT POCKETS IN WORLD REUSABLE INDUSTRIAL GLOVES MARKET, 20142020FIG. 5 TOP WINNING STRATEGIES OF GLOBAL SMART SYRINGES MARKET (2013-2015)FIG. 6 TOP WINNING STRATEGIES BY TYPE (2013-2015)FIG. 7 AGREEMENT STRATEGY BY TYPE (2011-2015)FIG. 8 PORTERS FIVE FORCES ANALYSIS OF WORLD SMART SYRINGES MARKETFIG. 9 VALUE CHAIN ANALYSISFIG. 10 MARKET SHARE ANALYSIS OF WORLD SMART SYRINGES MARKET, 2014 ($MILLION)FIG. 11 FREQUENCY (%) OF NEEDLE STICK INJURIES ACROSS DIFFERENT PROFESSIONFIG. 12 BECTON DICKINSON AND COMPANY REVENUE (2012-2014)FIG. 13 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY BY SEGMENT (2014)FIG. 14 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY BY GEOGRAPHY (2014)FIG. 15 SWOT ANALYSIS OF BECTON DICKINSON AND COMPANYFIG. 16 KEY FINANCIALS OF MEDTRONIC, INC. BY OPERATING SEGMENT (2014)FIG. 17 KEY FINANCIALS OF MEDTRONIC, INC. BY GEOGRAPHY (2014)FIG. 18 SWOT ANALYSIS OF MEDTRONIC, INC.FIG. 19 TERUMO MEDICAL CORPORATION FINANCIAL REVENUES BY BUSINESS SEGMENT (2014)FIG. 20 TERUMO MEDICAL CORPORATION FINANCIAL REVENUES BY GEOGRAPHY (2014)FIG. 21 SWOT ANALYSIS OF TERUMO MEDICAL CORPORATIONFIG. 22 B. BRAUN FINANCIAL REVENUES BY BUSINESS SEGMENT, 2014FIG. 23 B. BRAUN FINANCIAL REVENUES BY GEOGRAPHY, 2014FIG. 24 SWOT ANALYSIS OF B. BRAUN MELSUNGEN AGFIG. 25 BAXTER INTERNATIONAL REVENUE BY BUSINESS SEGMENTS (2013)FIG. 26 BAXTER INTERNATIONAL REVENUE BY GEOGRAPHY (2013)FIG. 27 SWOT ANALYSISFIG. 28 SMITHS GROUP FINANCIAL REVENUES BY BUSINESS SEGMENT (2014)FIG. 29 SMITHS GROUP FINANCIAL REVENUES BY GEOGRAPHY (2014)FIG. 30 SWOT ANALYSIS OF SMITHS GROUP PLCFIG. 31 KEY FINANCIALS OF UNILIFE CORPORATION ($MILLION)FIG. 32 UNILIFE CORPORATION GEOGRAPHIC FINANCIAL REVENUES BY BUSINESS SEGMENT (2015)FIG. 33 SWOT ANALYSIS OF UNILIFE CORPORATIONFIG. 34 REVOLUTIONS MEDICAL CORPORATION FINANCIAL REVENUES BY YEARFIG. 35 SWOT ANALYSIS OF REVOLUTIONS MEDICAL, INC.FIG. 36 RETRACTABLE TECHNOLOGIES, INC. FINANCIAL REVENUES BY YEAR (2011-2014)FIG. 37 RETRACTABLE TECHNOLOGIES, INC. FINANCIAL REVENUE BY GEOGRAPHY (2014)FIG. 38 SWOT ANALYSIS OF RETRACTABLE TECHNOLOGIES, INC.List of TablesTABLE 1 WORLD SMART SYRINGES MARKET, MODERATE GROWTH SCENARIO, 2020-2025($MILLION)TABLE 2 WORLD SMART SYRINGES MARKET, RAPID GROWTH SCENARIO, 2020-2025($MILLION)TABLE 3 WORLD SMART SYRINGES MARKET, DIMINISHING GROWTH SCENARIO, 2020-2025($MILLION)TABLE 4 WORLD SMART SYRINGES MARKET REVENUE, BY TYPE, 2014-2020 ($MILLION)TABLE 5 WORLD SMART SYRINGES MARKET VOLUME, BY TYPE, 2014-2020TABLE 6 WORLD SMART SYRINGES MARKET REVENUE, BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 7 WORLD SMART SYRINGES MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 8 WORLD AUTO DISABLE SYRINGES MARKET REVENUE, BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 9 WORLD AUTO DISABLE SYRINGES MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 10 WORLD ACTIVE SYRINGES MARKET REVENUE, BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 11 WORLD ACTIVE SYRINGES MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 12 WORLD PASSIVE SYRINGES MARKET VOLUME, BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 13 WORLD PASSIVE SYRINGES MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 14 WORLD SMART SYRINGES MARKET REVENUE, BY APPLICATION, 2014-2020 ($MILLION)TABLE 15 WORLD SMART SYRINGES MARKET VOLUME, BY APPLICATION, 2014-2020TABLE 16 WORLD SMART SYRINGES APPLICATION MARKET REVENUE, BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 17 WORLD SMART SYRINGES APPLICATION MARKET VOLUME, BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 18 WORLD SMART SYRINGES CURATIVE PURPOSES MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 19 WORLD SMART SYRINGES DRUG DELIVERY MARKET VOLUME, BY GEOGRAPHY, 2014-2020,TABLE 20 WORLD SMART SYRINGES VACCINATION MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 21 WORLD SMART SYRINGES VACCINATION MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 22 WORLD SMART SYRINGES VACCINATION MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 23 WORLD SMART SYRINGES VACCINATION MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 24 WORLD SMART SYRINGES MARKET REVENUE, BY END USER, 2014-2020, ($MILLION)TABLE 25 WORLD SMART SYRINGES END USER MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 26 WORLD SMART SYRINGES END USER MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 27 WORLD SMART SYRINGES END USER MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 28 WORLD SMART SYRINGES HOSPITALS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 29 WORLD SMART SYRINGES HOSPITALS MARKET VOLUME, BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 30 WORLD SMART SYRINGES DIABETIC PATIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 31 WORLD SMART SYRINGES DIABETIC PATIENTS MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 32 WORLD SMART SYRINGES FAMILY PRACTICES MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 33 WORLD SMART SYRINGES DIABETIC PATIENTS MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 34 WORLD SMART SYRINGES PSYCHIATRICS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 35 WORLD SMART SYRINGES PSYCHIATRICS MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 36 WORLD SMART SYRINGES OTHERS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 37 WORLD SMART SYRINGES OTHERS MARKET VOLUME, BY GEOGRAPHY, 2014-2020TABLE 38 WORLD SMART SYRINGES APPLICATION MARKET REVENUE, BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 39 WORLD SMART SYRINGES APPLICATION MARKET VOLUME, BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 40 NORTH AMERICA SMART SYRINGES MARKET REVENUE, BY APPLICATION, 2014-2020 ($MILLION)TABLE 41 NORTH AMERICA SMART SYRINGES MARKET VOLUME, BY APPLICATION, 2014-2020TABLE 42 EUROPE SMART SYRINGES MARKET REVENUE, BY APPLICATION, 2014-2020, ($MILLION)TABLE 43 EUROPE SMART SYRINGES MARKET VOLUME, BY APPLICATION, 2014-2020TABLE 44 ASIA PACIFIC SMART SYRINGES MARKET REVENUE, BY APPLICATION, 2014-2020, ($MILLION)TABLE 45 ASIA PACIFIC SMART SYRINGES MARKET VOLUME, BY APPLICATION, 2014-2020TABLE 46 LAMEA SMART SYRINGES MARKET REVENUE, BY APPLICATION, 2014-2020, ($MILLION)TABLE 47 LAMEA SMART SYRINGES MARKET VOLUME, BY APPLICATION, 2014-2020TABLE 48 BECTON DICKINSON AND COMPANY SNAPSHOTTABLE 49 COMPANY SNAPSHOT OF MEDTRONIC, INC.TABLE 50 COMPANY SNAPSHOT OF TERUMO MEDICAL CORPORATIONTABLE 51 COMPANY SNAPSHOT OF B. BRAUN MELSUNGEN AGTABLE 52 COMPANY SNAPSHOT OF BAXTER INTERNATIONALTABLE 53 COMPANY SNAPSHOT OF SMITHS GROUP PLCTABLE 54 COMPANY SNAPSHOT OF UNIFIFE CORPORATIONTABLE 55 COMPANY SNAPSHOT OF REVOLUTIONS MEDICAL CORPORATIONTABLE 56 COMPANY SNAPSHOT OF RETRACTABLE TECHNOLOGIES, INC.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The North American drug delivery technologies market is projected to reach USD 758.7 billion by 2021 from USD 520.0 billion in 2016, at a CAGR of 6.5% during the forecast period. Major factors contributing ...

Syringes Market by Usability & Disposable Syringes), Material, Type - Global Forecast to 2021

Syringes Market by Usability & Disposable Syringes), Material, Type - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The syringes market is expected to reach USD 15.99 billion by 2021, at a CAGR of 8.7% from 2016 to 2021. The syringes market is primarily driven by the high prevalence of chronic diseases across the globe. ...

Injectable Drug Delivery Market Analysis, By Device Type, By Formulation, By Therapeutic Use, By End-user Application, By Region And Segment Forecasts From 2013 to 2024

Injectable Drug Delivery Market Analysis, By Device Type, By Formulation, By Therapeutic Use, By End-user Application, By Region And Segment Forecasts From 2013 to 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The global injectable drug delivery market is expected to reach USD 931.1 billion by 2024, according to a new report by Grand View Research, Inc. The increase in number of chronic diseases like diabetes ...

Drug Injection Devices To 2024

August 2016 $ 3850

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.